Global Sleep Apnea Devices, By Diseases Type (Obstructive Sleep Apnea Syndrome, Central Sleep Apnea Syndrome, Complex Sleep Apnea Syndrome), Type (Devices, Therapy), Patient Demographics (Pediatric, Adult, Geriatric), End-User (Hospital/ Clinics, Diagnostic Centers, Ambulatory Care Centers, Specialty Care Centers, Home Healthcare), Distribution Channel (Direct Tender, Retail Sales) – Industry Trends and Forecast to 2030.
Sleep Apnea Devices Market Analysis and Size
Sleep apnea devices are widely used for facilitating and managing breathing in sleep apnea patients. Sleep apnea devices facilitate steady oxygen flow, and help in airway management and normal breathing.
Data Bridge Market Research analyses that the global sleep apnea devices which was USD 4,123.98 million in 2022, is expected to reach USD 7,723.98 million by 2030, and is expected to undergo a CAGR of 7.7% during the forecast period of 2023 to 2030. “Obstructive Sleep Apnea Syndrome” dominates the disease type segment of the global sleep apnea devices due to increasing incidence of sleep disorders. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Sleep Apnea Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Diseases Type (Obstructive Sleep Apnea Syndrome, Central Sleep Apnea Syndrome, Complex Sleep Apnea Syndrome), Type (Devices, Therapy), Patient Demographics (Pediatric, Adult, Geriatric), End-User (Hospital/ Clinics, Diagnostic Centers, Ambulatory Care Centers, Specialty Care Centers, Home Healthcare), Distribution Channel (Direct Tender, Retail Sales)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
NIHON KOHDEN CORPORATION (Japan), Koninklijke Philips N.V. (Netherlands), GENERAL ELECTRIC COMPANY (U.S.), Siemens Healthcare Private Limited (Germany), Natus Medical Incorporated (U.S.), Compumedics Limited (Australia), Electrical Geodesics, Inc (U.S.), CAS Medical Systems Inc (U.S.), Advanced Brain Monitoring (U.S.), B. Braun Medical (Germany), BD (U.S.), DePuySynthes Companies (U.S.), Cadwell Industries, Inc. (U.S.), Masimo Corporation (U.S.), Elekta AB (Sweden), Integra LifeSciences Corporation (U.S.), Rimed Inc. (Israel), Yokogawa Electric Corporation (Japan), EMOTIV Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Sleep apnea refers to a sleep disorder where breathing stops for at least 10 seconds in the affected individual, resulting in disrupted and irregular breathing patterns. The disorder reduces the oxygen saturation in the blood that circulates in the body. Sleep apnea devices are generally used as therapeutic and diagnostic devices for treating central sleep apnea syndrome, complex sleep apnea syndrome and obstructive sleep apnea syndrome.
Global Sleep Apnea Devices Market Dynamics
Drivers
- High Prevalence of Sleep Apnea
The primary driver of the global sleep apnea devices market is the high prevalence of sleep apnea worldwide. The disorder affects millions of individuals, and a significant portion of the population remains undiagnosed. As awareness grows and diagnosis rates increase, the demand for sleep apnea devices rises. To capitalize on this driver, manufacturers continuously innovate to develop user-friendly and effective devices for diagnosis and treatment.
- Healthcare Policies and Insurance Coverage
Many healthcare policies and insurance providers now cover the cost of sleep apnea diagnosis and treatment, including the purchase of devices. This increased insurance coverage reduces financial barriers for patients seeking devices. To leverage this driver, manufacturers work closely with healthcare stakeholders and insurers to ensure their products meet coverage criteria.
- Growing Awareness of Sleep Disorders
Growing awareness of sleep disorders and their impact on overall health has led to higher rates of diagnosis. Patients are more likely to seek treatment when they recognize the signs and symptoms of sleep apnea, driving demand for devices. To capitalize on this driver, manufacturers engage in educational initiatives and public awareness campaigns.
Opportunities
- Adoption of Home Sleep Testing
The adoption of home sleep testing (HST) devices has gained momentum, offering a convenient and cost-effective alternative to in-laboratory polysomnography. Manufacturers have an opportunity to develop and market HST devices that enable patients to monitor their sleep in the comfort of their homes. To seize this opportunity, companies invest in user-friendly HST technology and collaborate with healthcare providers for remote monitoring.
- Customized Sleep Apnea Devices
The development of customized sleep apnea devices tailored to individual patient needs and preferences is a promising avenue. Personalized solutions can enhance comfort and treatment adherence. To harness this opportunity, manufacturers invest in customization capabilities and collaborate with healthcare providers to offer patient-specific devices.
Restraints/Challenges
- High Costs of Sleep Apnea Devices
Sleep apnea devices, especially high-quality CPAP machines, can be relatively expensive. The cost of devices can be a significant restraint, particularly for patients without insurance coverage or in regions with limited access to affordable healthcare. To address this restraint, manufacturers explore cost-effective device options and financing programs.
-
Complex Diagnosis and Treatment
Sleep apnea diagnosis and treatment can be complex and multifaceted, involving various devices and interventions. Coordinating comprehensive care and ensuring patient understanding can be challenging. To tackle this challenge, healthcare providers and manufacturers collaborate on integrated care models and patient education.
This global sleep apnea devices report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global Sleep Apnea Devices Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In January 2021, ResMed made a strategic move by acquiring Ectosense to enhance its market presence and bolster the diagnosis of sleep apnea. This acquisition enables ResMed to tap into a significant underserved market, with over 80% of the global sleep apnea population, estimated at 936 million individuals, yet to be diagnosed.
Global Sleep Apnea Devices Scope
The global sleep apnea devices are segmented on the basis of disease type, type, patient demographics, end-user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Diseases Type
- Obstructive Sleep Apnea Syndrome
- Central Sleep Apnea Syndrome
- Complex Sleep Apnea Syndrome
Type
- Devices
- Therapy
Patient Demographics
- Pediatric
- Adult
- Geriatric
End-User
- Hospital/Clinics
- Diagnostic Centers
- Ambulatory Care Centers
- Specialty Care Center
- Home Healthcare
Distribution Channel
- Direct Tender
- Retail Sales
Global Sleep Apnea Devices Regional Analysis/Insights
The global sleep apnea devices are analysed and market size insights and trends are provided by disease type, type, patient demographics, end-user and distribution channel as referenced above.
The countries covered in the global sleep apnea devices report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the global sleep apnea devices in terms of market share and market revenue and will continue to flourish its dominance during the forecast period of 2023 to 2030, due of the increase in the expenditure for research and development proficiencies, increasing government’s initiatives and improved health care infrastructure in various countries.
Asia-Pacific on the other hand is projected to exhibit the highest growth rate in the global sleep apnea devices during the forecast period of 2023 to 2030 owing to the increasing government expenditure on healthcare sector and rising technological advancements and initiatives by the government.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global sleep apnea devices also provide you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global sleep apnea devices, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global sleep apnea devices. The data is available for historic period 2015 to 2020.
Competitive Landscape and Global Sleep Apnea Devices Share Analysis
The global sleep apnea devices competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company's focus related to global sleep apnea devices.
Some of the major players operating in the global sleep apnea devices are:
- NIHON KOHDEN CORPORATION (Japan)
- Koninklijke Philips N.V. (Netherlands)
- GENERAL ELECTRIC COMPANY (U.S.)
- Siemens Healthcare Private Limited (Germany)
- Natus Medical Incorporated (U.S.)
- Compumedics Limited (Australia)
- Electrical Geodesics, Inc (U.S.)
- CAS Medical Systems Inc (U.S.)
- Advanced Brain Monitoring (U.S.)
- B. Braun Medical (Germany)
- BD (U.S.)
- DePuySynthes Companies (U.S.)
- Cadwell Industries, Inc. (U.S.)
- Masimo Corporation (U.S.)
- Elekta AB (Sweden)
- Integra LifeSciences Corporation (U.S.)
- Rimed Inc. (Israel)
- Yokogawa Electric Corporation (Japan)
- EMOTIV Inc. (U.S.)
SKU-